Cargando…
The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study
BACKGROUND: Prolonged systemic antibiotic treatment is often a part of management of hidradenitis suppurativa (HS). Although biologic therapies are now available, the patient’s treatment journey leading to biologic therapy is unclear. OBJECTIVES: To examine treatment patterns and duration of systemi...
Autores principales: | Ring, Hans Christian, Yao, Yiqiu, Maul, Julia‐Tatjana, Ingram, John R., Frew, John W., Thorsen, Jonathan, Nielsen, Mia‐Louise, Wu, Jashin J., Thyssen, Jacob P., Thomsen, Simon F., Egeberg, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796665/ https://www.ncbi.nlm.nih.gov/pubmed/35603888 http://dx.doi.org/10.1111/bjd.21673 |
Ejemplares similares
-
Considerable improvement in hidradenitis suppurativa with oral roflumilast therapy
por: Ring, Hans Christian, et al.
Publicado: (2022) -
Decreased glomerular function is associated with disease severity in patients with hidradenitis suppurativa
por: Nielsen, Valdemar W., et al.
Publicado: (2022) -
Adalimumab for the Treatment of Periodontitis in a 35-Year-Old Woman with Hidradenitis Suppurativa
por: Yao, Yiqiu, et al.
Publicado: (2023) -
Liver enzyme levels are associated with markers of systemic inflammation, disease severity, and metabolic syndrome in patients with hidradenitis suppurativa
por: Nielsen, Valdemar Wendelboe, et al.
Publicado: (2021) -
Therapeutic Response to Secukinumab in a 36-Year-Old Woman with Hidradenitis Suppurativa
por: Jørgensen, Astrid-Helene Ravn, et al.
Publicado: (2018)